Diabetes Clinical Trials in New York

Showing 21-40 of 582 trials

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

NCT06525259

The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic determinates, in obese adolescents at risk for developing type 2 diabetes.

Diabetes Mellitus Type 2, Childhood-Onset

George Washington University3,600 participantsStarted Oct 2024

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +17 more locations

COMPLETEDNA< 1 mile

The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

NCT06111508

The goal of this clinical trial is to compare the effect of a continuous glucose monitor (CGM) based titration algorithm to standard titration by self-monitoring blood glucose (SMBG) in participants with Type 2 Diabetes already using long acting insulin. The comparison aims to study the difference in glycemic control between the two therapies. Participants will be followed for 18 weeks and will be provided with Degludec insulin, insulin pen, and a CGM (Dexcom G6).

Type 2 Diabetes

University of Virginia30 participantsStarted Nov 2023

New York, New York, United States • Charlottesville, Virginia, United States

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

Diabetes Trials in Other Cities

Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

Siplizumab in T1DM

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

Type 1 Diabetes Extension Study

Teplizumab in Pediatric Stage 2 Type 1 Diabetes

A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Closed Loop and Education for Hypoglycemia Awareness Restoration

Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs

Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes

Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D)

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment

Other Conditions in New York